Research ArticleCancer

COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models

See allHide authors and affiliations

Science Translational Medicine  25 Jun 2014:
Vol. 6, Issue 242, pp. 242ra84
DOI: 10.1126/scitranslmed.3008455

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article